Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rod Passman

Clinical Cardiac Electrophysiology Chicago, IL Medical Doctor

NPI 1982639688 CMS profile 561761

680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611

Open in the dashboard

General payments

$92,412

267 records reported · program years 2019–2025

Research payments

$29,074

Paid to them · 23 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$51,488 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Rod Passman of Chicago, IL is reported in the CMS Open Payments database as having received $92,412 across 267 general payments and $29,074 in research payments paid to them. Separately, studies naming them as principal investigator received $51,488 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,843 45
2025 Research $1,191 1
2024 General $27,450 69
2024 Research $3,205 3
2023 General $20,825 48
2023 Research $3,607 3
2022 General $8,862 43
2022 Research $6,169 7
2021 General $6,890 26
2021 Research $2,012 4
2020 General $5,354 7
2020 Research $12,891 5
2019 General $7,188 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rod Passman
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Rod Passman were reported at $15,843. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Rod Passman Clinical Cardiac Electrophysiology median Middle half National median
2019 $7,188 $2,361 $585–$8,260 $163
2020 $5,354 $993 $247–$4,351 $114
2021 $6,890 $1,185 $326–$4,739 $132
2022 $8,862 $2,073 $554–$6,789 $149
2023 $20,825 $2,568 $759–$8,159 $160
2024 $27,450 $2,557 $703–$7,403 $164
2025 $15,843 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $34,781 81 payments
  2. Boston Scientific Corporation $21,924 77 payments
  3. iRhythm Technologies, Inc. $9,905 10 payments
  4. Medtronic Vascular, Inc. $8,178 12 payments
  5. Abbott Laboratories $6,742 47 payments
  6. Medical Device Business Services, Inc. $5,431 1 payment
  7. Sanofi-Aventis U.S. LLC $2,556 1 payment
  8. Biotronik Inc. $839 10 payments
  9. Janssen Scientific Affairs, LLC $444 5 payments
  10. Ge Healthcare $337 1 payment
  11. Other $1,275 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $34,002 9 payments
  2. Consulting Fee $33,847 20 payments
  3. Travel and Lodging $12,667 45 payments
  4. Food and Beverage $11,896 193 payments
Products named General payments · program years 2019–2025
  1. ZIO XT Patch $9,905 10 payments
  2. Arctic Front $5,974 4 payments
  3. Carto 3 $5,591 2 payments
  4. General - Therapies General - Therapies_EP $5,143 2 payments
  5. MULTAQ $2,556 1 payment
  6. ENSITE $1,534 4 payments
  7. Confirm Rx $1,200 1 payment
  8. Quartet CRT Lead $1,200 2 payments
  9. Allure CRT Pacemaker $776 5 payments
  10. General - Therapies General - Therapies_CRM $625 1 payment
  11. Other $7,684 133 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Janssen Scientific Affairs, LLC $18,662 11 payments
  2. Medtronic Vascular, Inc. $5,250 2 payments
  3. Medtronic, Inc. $5,162 10 payments

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

1,309

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$693,018

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

43.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 293 $392,481
Multaq Dronedarone Hcl Brand 88 $135,646
Xarelto Rivaroxaban Brand 97 $126,315
Dofetilide Generic 36 $12,336
Flecainide Acetate Generic 223 $9,763
Propafenone Hcl Er Propafenone Hcl Brand 20 $6,057
Amiodarone Hcl Generic 296 $5,305
Metoprolol Succinate Generic 137 $3,288
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 44 $925
Warfarin Sodium Generic 25 $339

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$166,910

Medicare's payments for the services billed

Medicare patients

578

Average age 78

Services billed

2,564

230 women, 348 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 72%
Arthritis 48%
Ischemic heart disease 43%
Heart failure 39%
Chronic kidney disease 31%
Diabetes 26%
Cancer 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Wegovy
  • Novo Nordisk Inc $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

290 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record